GEMA supercedes traditional plasmapheresis technology
The GEMA plasmapheresis machine is our flagship device, representing decades of research and innovation. It offers a streamlined, patient-friendly experience, dramatically improving the efficiency and outcomes of plasma exchange procedures.
-
Embodiment of our commitment to innovation and excellence - Combines the expertise of our founders with the latest medical technology
- Replaces bulky and invasive machines of the past
Addressing Outdated Plasmapheresis Practices
Our dedication to advancing plasmapheresis is rooted in addressing the critical shortcomings of traditional methods:
High Blood Volume Requirements
Traditional machines demand large volumes of blood to fill their circuits—often 400-500 ml per procedure. This excessive volume leads to numerous clinical issues, including hypotension, discomfort, anxiety, and other complications during treatment.
Extended Procedure Times
With outdated machines, sessions can exceed three hours, leaving patients immobilized for prolonged periods, further adding to their discomfort and stress.
Traumatic Access Methods
Many older devices require accessing the internal jugular or subclavian veins, which is highly invasive and traumatic for patients. These procedures add unnecessary stress and discomfort, particularly for vulnerable patients.
The Apheresis Technology Advantage
Recognizing these significant shortcomings, Apheresis Technology has developed devices that are years ahead of traditional plasmapheresis technology. Our GEMA machine and related devices are designed to minimize patient trauma, reduce the amount of blood required for the procedure, and dramatically shorten the time patients need to spend undergoing treatment. These innovations not only improve patient comfort and safety but also enhance the overall efficiency of medical facilities.
Revolutionizing Plasmapheresis: Journey
of Innovation and Patient-Centered Care
of Innovation and Patient-Centered Care
1
Founding Vision
Apheresis Technologies was founded by Alexey Zumbana to revolutionize plasmapheresis with modern, efficient solutions. The co-founders recognized the need for innovation in a field limited by outdated, ineffective devices.
2
Mission of Innovation
With over 25 years of experience, the company aims to lead the industry by delivering advanced plasmapheresis technology that surpasses the limitations of older machines, focusing on safety and efficiency.
3
Global Leadership
Apheresis Technologies is a recognized leader in the field across Europe, Latin America, and beyond, thanks to its innovative approach and commitment to advancing medical technology.
4
GEMA: The Future of Plasmapheresis
GEMA, the company’s flagship device, combines decades of research with the latest advancements to offer a streamlined, patient-friendly experience, improving plasma exchange procedures.
5
Patient-Centered Approach
Unlike traditional machines, GEMA prioritizes patient comfort and safety, providing a more humane and efficient plasma exchange experience.
Collaborations and Impact
Extensive Collaborations
We partner with leading universities, research institutes, and medical clinics across Russia, Eurasia, and beyond to advance plasmapheresis technology.
Rigorous Research and Development
Our R&D focuses on improving membrane and sorption processes and enhancing polymeric materials, ensuring our devices lead in innovation.
Expert Scientific Advisors
Our team includes renowned experts in medicine, biotechnology, and nanotechnology, keeping our products at the cutting edge of medical advancements.
Core of the Healthcare Ecosystem
We drive the progress of personalized medicine, digitalization, and efficiency in medical institutions, aiming for better outcomes across the healthcare spectrum.
Global Leaders in Plasmapheresis and Social Impact
Social Impact
Apheresis Technology, through Feres Technology, funds social projects for immunological disease patients, focusing on the Guillain-Barré Foundation, the world's largest organization for treating Guillain-Barré Syndrome and similar disorders.
Comprehensive Plasma Services
Apheresis Technology leads in plasmapheresis services, operating the largest Latin American clinic and expanding globally with locations in Europe, Dubai, Mexico, and the U.S., while collaborating with governments worldwide.
Social Responsibility:
The Guillain-Barré Foundation
The Guillain-Barré Foundation
Apheresis Technology is committed to social responsibility through our Guillain-Barré Foundation, the largest organization in Latin America focused on treating Guillain-Barré Syndrome. Operating in Ecuador, Mexico, Armenia, and Russia, we provide essential medical support to patients with complex immunological diseases. Our foundation embodies our belief in healthcare as a universal right, dedicated to making a global impact.
Consulting and Training Services
Apheresis Technology is at the forefront of plasmapheresis, with a proven track record and a commitment to innovation.
-
Widespread AdoptionOur technologies are used in over 850 clinics across Russia, Ukraine, Belarus, Kazakhstan, Azerbaijan, and Moldova, with over 550,000 procedures successfully performed. -
Global ExpansionOur devices have been tested and implemented in Africa and South America, validating their effectiveness and reliability worldwide. -
Expert TeamOur experienced team, with decades in membrane technology and medical device engineering, drives our success and innovation. -
Industry RecognitionWe’ve received numerous awards, including commendations from the Governor of St. Petersburg and the Legislative Assembly of the Leningrad Region. -
Prestigious AffiliationsAs active members of several leading industry organizations, we continue to set the standard in medical technology and plasmapheresis services. -
Global CollaborationWe are open to partnerships with medical institutions worldwide, dedicated to enhancing patient care and health outcomes through superior technology.
“
At Apheresis Technology, we don’t merely challenge the conventional—we transcend it with solutions that shape the future of medicine. Our advanced technology goes beyond innovation; it embodies our commitment to excellence, with each device engineered to deliver safer, more effective, and patient-focused treatments. We're not just improving the present; we're creating what was once deemed impossible.
Get in touch
